Edelweiss Pharma Analytica Acta is a double blind peer reviewed Open Access journal that aims to publish most complete and reliable source of information on the findings and current developments in the form of case reports, original research and review articles, and short communications and making them freely available to everyone immediately after publication.

Branches of pharmaceutics includes advances in pharmaceutical analytical methods, air analysis, chemical analysis, Competitive analysis of drugs, Drug analysis, Pharmaceutical analysis, Pharmaceutical analytical market, Pharmaceutical analytical market, Pharmaceutical technology, Pharmaceutical formulation, Pharmaceutics, Quality assurance in pharmaceutical analysis, Spectrometry, Validation. Edelweiss Pharma Analytica Acta is the Journal maintained by Edelweiss publications, which ensures of Rapid Peer review with the help of its Editorial Board.

Authors may submit their valuable research at: edelweisspublications@gmail.com

Edelweiss Pharma Analytica Acta follows peer-review process and upon acceptance of article under review process, the article processing fee 500USD is charged accordingly to publish and make it available to all the levels of scientific community without any hassle.

Editorial Board

The Journal Edelweiss Pharma Analytica Acta consists of Editorial Board members from all over the world who help us in rapid peer review process (4-6 weeks).

Alain L Fymat, Professor, International Institute of Medicine and Science, USA

Cody P Coyne, Professor, Molecular Pharmacology and Immunology, Department of Basic Sciences, Mississippi State University, USA

Robert P Bianchi, President and Chief of Scientific and Technical Affairs, Prescription Drug, Research Center, Chicago, USA

For more Editorial broad members